Intratumoral delivery of RIG-I agonist SLR14 induces robust antitumor responses

Journal: Journal of Experimental Medicine

Published: 2019-12-02

DOI: 10.1084/jem.20190801

Affiliations: 8

Authors: 8

Go to article
Institutions Share
Yale University, United States of America (USA) 0.88
Yale Cancer Center, United States of America (USA) 0.13
Howard Hughes Medical Institute (HHMI), United States of America (USA) 0

Return